Biologicals

Plant vaccines

Vaccines are effective means of reducing the disease burden of infectious diseases in developing countries. To ensure the widest availability of these vaccines in poor countries, approaches are needed with lower production costs and less need of medical personnel to administer the vaccines. A promising avenue is the development of plant-derived vaccines, which can be administered orally or to other mucosal surfaces. Plants are able to produce different classes of proteins of pharmaceutical significance at a high yield, leading to potentially inexpensive products. Oral administration is important as it diminishes the need for needles and syringes which require highly trained immunization staff.


RELATED LINKS

UPCOMING EVENTS

WHO Drafting Group Meeting on the Revision of TRS 962, Annex 1

(Guidelines to assure the quality, safety and efficacy of recombinant human papillomavirus virus-like particle vaccines) 29-30 April 2014, WHO/HQ, Geneva

Implementation Workshop on Evaluation of Biotherapeutic Products and Evaluation of Similar Biotherapeutic products with emphasis on Monoclonal Antibody Products

13-16 May 2014, Seoul, The Republic of Korea

CONTACTS

Quality, Safety and Standards (QSS)
Immunization, Vaccines and Biologicals (IVB)
World Health Organization (WHO)
Avenue Appia 20
1211 Geneva 27, Switzerland
Fax No. +41 22 7914971